Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1437785 | 1.00 | NOS3 (0.32) | NOS3NOS1NOS2KMT2AALDH1A1 | |
| SCHEMBL258276 | 1.00 | — | — | |
| SCHEMBL21114222 | 1.00 | NOS3 (0.32) | NOS3NOS1NOS2KMT2AALDH1A1 | |
| SCHEMBL1437720 | 1.00 | NOS3 (0.32) | NOS3NOS1NOS2KMT2AALDH1A1 | |
| SCHEMBL96631 | 1.00 | NOS3 (0.32) | NOS3NOS1NOS2KMT2AALDH1A1 | |
| SCHEMBL73158 | 1.00 | — | — | |
| SCHEMBL27356307 | 0.97 | — | — | |
| SCHEMBL65158 | 0.96 | — | — | |
| SCHEMBL189624 | 0.89 | — | — | |
| SCHEMBL43432 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118290394-A | Preparation of light-controlled targeting GSPT protein degradation compound and application thereof in tumor treatment | 中国医学科学院药物研究所 | 2024-07-05 | — | — | CN | disclosed |
| EP-3845580-B1 | ALIPHATIC POLYESTER WITH HIGH ELONGATION | CHANG CHUN PLASTICS CO LTD (TW) | 2023-10-25 | — | — | EP | disclosed |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| EP-4114825-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-01-11 | — | — | EP | disclosed |
| CN-115210219-A | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-111138646-B | High ductility aliphatic polyester | 长春人造树脂厂股份有限公司 | 2022-06-07 | — | — | CN | disclosed |
| US-20220121113-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| EP-3044208-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2021-12-22 | — | — | EP | disclosed |
| EP-3914965-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2021-12-01 | — | — | EP | disclosed |
| CN-109790284-B | Polyphenol compound and process for producing the same | 三菱化学株式会社 | 2021-09-21 | — | — | CN | disclosed |
| US-20190210947-A1 | POLYHYDRIC PHENOL COMPOUND AND METHOD OF PRODUCING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-07-11 | — | — | US | disclosed |
| US-20180208583-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2018-07-26 | — | — | US | disclosed |
| US-9957258-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2018-05-01 | — | — | US | disclosed |
| US-20160214966-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2016-07-28 | — | — | US | disclosed |
| EP-3044208-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2016-07-20 | — | — | EP | disclosed |
| WO-2015036910-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2015-03-19 | — | — | WO | disclosed |
| US-6410748-B1 | Alicycli c group-containing monomer | KABUSHIKI KAISHA TOSHIBA (JP) | 2002-06-25 | — | — | US | disclosed |
| US-6291129-B1 | LIGHT SENSITIVE ELEMENT WITH UNSATURATED POLYMERS | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-09-18 | — | — | US | disclosed |
| US-5155268-A | Antiarrhythmic N-aminoalkylene alkyl and aryl sulfonamides | THE UPJOHN COMPANY (US) | 1992-10-13 | — | — | US | disclosed |
| EP-0164865-B1 | N-(AMINOALKYLPHENYL)SULFONAMIDES THEIR PREPARATION AND THERAPEUTIC USE | THE UPJOHN COMPANY (US) | 1988-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190210947-A1 | POLYHYDRIC PHENOL COMPOUND AND METHOD OF PRODUCING SAME | RB1, FHIT, H1-4 | NOS3 3204/4885NOS1 2733/4885NOS2 2117/4885 |
| US-20180208583-A1 | OXIME ESTER PHOTOINITIATORS | NR2E3, OXER1, CBR3 | NOS3 221/4885NOS1 241/4885NOS2 319/4885 |
| US-20160214966-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | NOS3 607/4885NOS1 769/4885NOS2 790/4885 |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | NOS3 301/4885NOS1 500/4885NOS2 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.